Novel artemisinin-based combination therapies for children exposed to high transmission of multiple Plasmodium species [ 2010 - 2014 ]

Also known as: New combination treatments for children with malaria

Research Grant

[Cite as]

Researchers: Prof Timothy Davis (Principal investigator) ,  A/Pr Harin Karunajeewa Prof Ivo Mueller Prof Kevin Batty Prof Peter Siba
View all 6 related researchers

Brief description We recently found that the WHO-recommended combination antimalarial therapy artemether-lumefantrine and the candidate regimen dihydroartemisinin-piperaquine were not fully effective for both falciparum and vivax malaria in young PNG children, a group at risk of complications and death. We plan to study two new combinations (artesunate-pyronaridine and artemisinin-naphthoquine) and hypothesise that at least one will prove superior and be used as first-line treatment in PNG and similar countries.

Funding Amount $AUD 1,378,408.08

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]